BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2004
View Archived Issues
Artekin may contribute to control of multidrug-resistant malaria
Read More
Enrollment complete in phase IV Visicol constipation study
Read More
Preclinical evidence for the antiviral efficacy of interferon alpha in SARS
Read More
Duloxetine improves voiding and quality of life of women with stress urinary incontinence
Read More
Clinical development of CAB-175 discontinued
Read More
Genzyme to acquire Ilex Oncology
Read More
Reorganization of indiplon agreements
Read More
Active Biotech discontinues discovery projects, focuses on development
Read More
Biovail acquires rights to novel formulations of eprosartan and carvedilol
Read More
Reolysin program update
Read More
Integrin alphavbeta3 antagonist and bone resorption inhibitor characterized for further development
Read More
Randomization completed in candesartan diabetic retinopathy program
Read More
Pharmacological characterization of novel DPP IV inhibitor K-579
Read More
Successful completion of first phase I trial for nebulized rAAT
Read More
Identification of neural stem cells in adult human brain
Read More
Improved response found in vitiligo patches with tacrolimus and excimer laser
Read More
Four related series of LDL receptor upregulators presented by GSK
Read More
New antibacterial oxazolidinones presented by Orchid researchers
Read More
Novel HDAC inhibitors prepared and tested by 4SC and G2M scientists
Read More
New glucosylceramide synthase inhibitors identified at Oxford Glycosciences
Read More
Aventis claims the preparation and use of novel cysteine protease inhibitors
Read More
New xanthine oxidase inhibitors for inflammation, reperfusion disorders and gout
Read More
Uriach presents immunomodulators and proapoptotic agents in a recent patent
Read More
Two novel series of glycogenphosphorylase a inhibitors under study at Aventis
Read More
Sinus and Allergy Health Partnership guidelines recommend Omnicef
Read More
Kirin announces phase I clinical trial of KRN-125 and other recent developments
Read More
Preclinical data supports use of INGN-241 regimens for lung, breast cancer
Read More
Satraplatin shows in vitro efficacy in tumor cells resistant to Taxotere and Taxol
Read More
Advanced Viral Research reports in vitro biologic effects of AVR-118
Read More
Approvable letter for Estorra
Read More
Zadaxin shows efficacy in preclinical invasive aspergillosis study
Read More
Investigation of Viagra for FSAD to close
Read More